Application of MR-PET in Colorectal Cancer

National Taiwan University Hospital100 enrolled

Overview

This study will explore the potential value in proper therapeutic decision and clinical outcome prediction by using integrated MR-PET system and advanced MR techniques in patients with colorectal cancer.

This research expect that the image techniques and experience in this cancer group may be valuable and helpful for others. With advantage of MR-PET in better soft tissue delineation/functional information and less radiation dose than PET-CT, the ultimate goal in both research and clinical application is to establish new diagnostic standard and management guideline by MR-PET, which can further improve clinical outcome and disease prognosis in patients colorectal cancer.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Colorectal Cancer

Interventions

The imaging biomarkers determined by MR-PETDEVICE

Eligibility

Sex: ALLMin age: 20 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Group 1: Patients with newly diagnosed colorectal cancers 2. Group 2: Patients with suspicious recurrent colorectal cancers Exclusion Criteria: 1. Age \<20 or \>90 years old 2. Contraindication for MRI: claustrophobia or MR non-compatible devices 3. Contraindication for MR contrast medium: severe adverse reaction or impaired renal function (Cre \> 2.0) 4. History of other malignancy 5. Prior arthroplasty of hip (may cause artifacts on MRI) 6. Pregnancy

Locations (1)

National Taiwan University Hospital

Taipei, Taiwan

RECRUITING

Outcomes

Primary Outcomes

The recurrence rate at 1 year after surgery

Time frame: 1 year

Secondary Outcomes

The overall survival at 1 year after surgery

Time frame: 1 year

Central Contacts

Ting-Fang Shih, MD

CONTACT

+886-2-23123456 ttfshih@ntu.edu.tw

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.